Inhibition by beraprost sodium of thrombin-induced increase in endothelial macromolecular permeability

Effect of beraprost sodium (BPS), a long-acting and orally active stable analogue of PGI 2, on the macromolecular permeability of cultured vascular endothelial cells (HUVEC) was detected by the transport of FITC-albumin. Thrombin treatment resulted in induction of FITC-albumin transport across the e...

Full description

Saved in:
Bibliographic Details
Published inProstaglandins, leukotrienes and essential fatty acids Vol. 53; no. 2; pp. 103 - 108
Main Authors Imai-Sasaki, R., Kainoh, M., Ogawa, Y., Ohmori, E., Asai, Y., Nakadate, T.
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier Ltd 01.08.1995
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Effect of beraprost sodium (BPS), a long-acting and orally active stable analogue of PGI 2, on the macromolecular permeability of cultured vascular endothelial cells (HUVEC) was detected by the transport of FITC-albumin. Thrombin treatment resulted in induction of FITC-albumin transport across the endothelial cell monolayer. The albumin transport induced by thrombin was not accompanied by any damage to the cells. BPS had no effect on the permeability of resting endothelial monolayers, while BPS inhibited the thrombin-induced increase in the albumin permeability in a dose-dependent manner (30–1000 nM). Treatment of the cells with PGI 2 or dibutyryl cAMP caused a significant inhibition of the thrombin-induced increase in the albumin permeability. These results strongly suggested that BPS suppressed the thrombin-induced macromolecular permeability in HUVEC through the elevation of its intracellular cAMP, and that BPS was a suppressor against inflammatory vascular changes such as exudation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0952-3278
1532-2823
DOI:10.1016/0952-3278(95)90136-1